Fundación Gecp
Clinical trials sponsored by Fundación Gecp, explained in plain language.
-
New hope for mesothelioma patients: experimental drug tested in 47 people
Disease control CompletedThis study tested an experimental drug called Bintrafusp alfa in 47 people with advanced malignant pleural mesothelioma, a rare lung cancer, whose disease worsened after platinum-based chemotherapy. The goal was to see if the drug could slow tumor growth. Participants received th…
Phase: PHASE2 • Sponsor: Fundación GECP • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
Lung cancer & COVID: new study tracks immune response in nearly 2000 patients
Knowledge-focused CompletedThis study looked at nearly 2000 lung cancer patients to understand how their bodies build immunity after catching COVID-19 or getting vaccinated. Researchers collected medical records and tested blood for antibodies. The goal was to describe patient characteristics and immune re…
Sponsor: Fundación GECP • Aim: Knowledge-focused
Last updated May 22, 2026 14:03 UTC
-
Lung cancer study sheds light on hidden sexual struggles
Knowledge-focused CompletedThis study looked at sexual problems in 553 adults with lung cancer to find out how common and severe they are. The goal is to help doctors better manage and support patients' sexual health during and after cancer treatment. No new treatments were tested—only information was coll…
Sponsor: Fundación GECP • Aim: Knowledge-focused
Last updated May 22, 2026 13:51 UTC